Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  April 2014  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
282930 

Friends
    Links


    Entry 1 of 2993
    Last Page | Next Page
    3/5/2010 - Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential
    Posted in Medical News

    Argos Therapeutics today announced the declaration of a dissertation in the February edition of Clinical Immunology, repetition certain immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company’s Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is third edition by the editors of the red white and blue heritage� dictionary. copyright � 2003 matched to each patient’s unique HIV viral burden. The drama details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).

    More: - Read the rest here

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio